Drug Profile
Lurtotecan
Alternative Names: GG 211; GI 147211; GI 147211C; GW 211; Lurtotecan dihydrochlorideLatest Information Update: 16 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GlaxoSmithKline; Nonindustrial source
- Class Alkaloids; Antineoplastics; Camptothecins
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Ovarian cancer
Most Recent Events
- 03 Dec 1999 Discontinued-II for Cancer in Netherlands (Infusion)
- 03 Dec 1999 Discontinued-II for Cancer in United Kingdom (Infusion)
- 03 Dec 1999 Discontinued-II for Cancer in USA (Infusion)